Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes - Top-Institutions - MDSpire

Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes

  • By

  • Hannes Kaddatz

  • Lukas Wenzel

  • Emil Pril

  • Sophia Meien

  • Victoria Harz

  • Luisa Burkert

  • Newshan Behrangi

  • Annelie Zimmermann

  • Linda Frintrop

  • Sandra Amor

  • Markus Kipp

  • Leo Heinig

  • March 24, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurobiology
    • Neuroimmunology
    • Multiple Sclerosis Research

  • #2

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neuroscience
    • Neurodegeneration
    • Glial Biology

  • #3

    Washington University in St. Louis
    Washington University in St. Louis

    St. Louis, MO

    Key Differentiators

    • Neuroscience
    • Neuroimmunology
    • Myelin Biology

  • #4

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Neurobiology
    • Multiple Sclerosis

  • #5

    University of Cambridge
    University of Cambridge

    Cambridge, UK

    Key Differentiators

    • Neuroscience
    • Glial Cell Biology
    • Neurodegeneration

Original Source(s)

Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes

  • by Hannes Kaddatz, Lukas Wenzel, Emil Pril, Sophia Meien, Victoria Harz, Luisa Burkert, Newshan Behrangi, Annelie Zimmermann, Linda Frintrop, Sandra Amor, Markus Kipp, Leo Heinig

  • March 24, 2026

Related Content

The epidemiological trends of multiple sclerosis among women of child-bearing age: a global analysis from 1990 to 2021 and forecasts to 2040

Case Study: Ofatumumab-Induced Remission in Refractory Panuveitis Accompanied by Multiple Sclerosis

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.